US Patent 7820193 Anti-angiogenic compositions and methods of use
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+221 characters)
Article
Patent abstract
The present invention is directed to a stent comprising(a) a balloon expandable coronary stent; and(b) paclitaxel, in an amount that when tested in a chick chorioallantoic membrane assay is anti-angiogenic.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07820193 Anti-angiogenic compositions and methods of use US Patent 7820193 Anti-angiogenic compositions and methods of use
Infobox
Patent Number
0782019300
Patent Number
782019300
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
078201930
Date of Patent
October 26, 2010
0Patent Application Number
109593490
Date Filed
October 7, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
078201930
Date of Patent
October 26, 2010
0Patent Application Number
109593490
Date Filed
October 7, 2004
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07820193 Anti-angiogenic compositions and methods of use
Infobox
Is a
Patent jurisdiction
Patent number
07820193
Date of patent
October 26, 2010
Patent application number
10959349
Date Filed
October 7, 2004
Patent primary examiner
Find more entities like US Patent 7820193 Anti-angiogenic compositions and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
